Matrix Metalloproteinase 2
"Matrix Metalloproteinase 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
| Descriptor ID |
D020778
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.352 D08.811.277.656.300.480.252.420 D08.811.277.656.300.480.525.700.150 D08.811.277.656.675.374.205.352 D08.811.277.656.675.374.252.420 D08.811.277.656.675.374.525.700.150 D12.644.276.848.150 D12.776.467.836.150
|
| Concept/Terms |
Matrix Metalloproteinase 2- Matrix Metalloproteinase 2
- Metalloproteinase 2, Matrix
- 72-kDa Gelatinase
- 72 kDa Gelatinase
- Gelatinase, 72-kDa
- 72-kDa Type IV Collagenase
- 72 kDa Type IV Collagenase
- MMP-2 Metalloproteinase
- MMP 2 Metalloproteinase
- Metalloproteinase, MMP-2
- Gelatinase A
- MMP2 Metalloproteinase
- Metalloproteinase, MMP2
- Matrix Metalloproteinase-2
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 2".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 2".
This graph shows the total number of publications written about "Matrix Metalloproteinase 2" by people in this website by year, and whether "Matrix Metalloproteinase 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 5 | 6 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 2 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 2" by people in Profiles.
-
KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. PLoS Pathog. 2020 10; 16(10):e1009006.
-
Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial. Heart Rhythm. 2019 05; 16(5):743-753.
-
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations. Transl Stroke Res. 2018 02; 9(1):34-43.
-
Left Ventricular Unloading After Acute Myocardial Infarction Reduces MMP/JNK Associated Apoptosis and Promotes FAK Cell-Survival Signaling. Ann Thorac Surg. 2016 Dec; 102(6):1919-1924.
-
Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth. Int J Cancer. 2014 Aug 01; 135(3):551-62.
-
Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013 Sep; 28(9):2407-16.
-
Invited commentary. Ann Thorac Surg. 2013 Jan; 95(1):61-2.
-
GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med. 2013 Apr; 2(2):117-29.
-
Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study. Breast Cancer Res Treat. 2012 Dec; 136(3):837-45.
-
Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. Gene Ther. 2013 Mar; 20(3):318-27.